Form 4: Clifford Sosin of CAS Investment Partners Increases Stake in Cardlytics, Inc.

Clifford Sosin, Managing Member of CAS Investment Partners, reports increased beneficial ownership in Cardlytics, Inc. through recent common stock purchases and holdings of convertible senior notes.

Summary

• Clifford Sosin, through CAS Investment Partners, has increased his stake in Cardlytics, Inc.
• On May 9, 2024, 225,000 shares of common stock were purchased at $8.7275 per share.
• On May 10, 2024, an additional 100,000 shares were purchased at $8.7854 per share.
• A further 3,746 shares were acquired on May 13, 2024, at $8.986 per share.
• Following these transactions, Sosin's beneficial ownership amounts to 6,464,859 shares of common stock.
• Sosin Master, L.P. directly holds $16,498,366 principal amount of Cardlytics' 4.25% Convertible Senior Notes due April 1, 2029.
• CSWR Partners, L.P. directly holds $7,501,634 principal amount of the same notes.
• The notes are convertible into common stock at an initial rate of 55.4939 shares per $1,000 principal amount, subject to adjustments.
• The issuer has the option to settle conversions in cash, shares, or a combination thereof.

Sentiment

Score: 7

Explanation: Increased investment by a significant shareholder is generally a positive signal, suggesting confidence in the company's prospects. However, the document lacks broader context on the company's performance.

Positives

• Increased investment by a significant shareholder (Clifford Sosin) could signal confidence in Cardlytics' future prospects.
• The purchase of common stock at increasing prices ($8.7275 to $8.986) may indicate a positive outlook on the company's valuation.
• The holdings of convertible senior notes provide potential future equity if converted.

Risks

• The issuer's option to settle note conversions in cash could dilute the impact of potential equity conversion.
• The conversion rate of the notes is subject to adjustment, which could affect the number of shares ultimately received upon conversion.
• The document does not provide any information on the overall financial health or performance of Cardlytics, Inc.

Industry Context

Form 4 filings are standard disclosures for significant shareholders, providing transparency into their investment activities. Increased ownership by a major investor is often viewed positively by the market.

Comparison to Industry Standards

• Form 4 filings are a standard part of regulatory compliance for individuals and entities holding significant positions in publicly traded companies.
• Similar filings are made by major shareholders in companies like Visa, Mastercard, and American Express, which operate in related sectors to Cardlytics.
• The size of the transactions and holdings are relative to the market capitalization of Cardlytics and the investment strategy of CAS Investment Partners.

Stakeholder Impact

• Shareholders may view the increased investment positively.
• Employees may see it as a sign of stability and growth potential.
• The impact on customers, suppliers, and creditors is not directly addressed in this document.

Key Dates